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Intersecting Epidemics
Estimated 73% of annual HCV infections 
in KY, VA, TN, WV are among people who 
inject drugs (PWID). 
4-fold increase in annual acute HCV 
cases between 2005 and 2016.
2-fold increase in drug overdoses 
between 2007 and 2017.
Approximately 75% of PWID in the U.S. 
with HIV are infected with HCV. 
TN: 24.5
US: 19.69
TN: 334
US: 251.3
TN: 31.97
US: 13.9 TN: 12.8
US: 14.7
Source: amfAR Opioid & Health Indicators Database
Drug-related Deaths, 2016
• US: 19.69 per 100,000
• TN: 24.5 per 100, 000
• District: 23.5 per 100,000
New HIV Diagnoses, 2016
• US: 14.7 per 100,000
• TN: 12.8 per 100, 000
• District: 2.03 per 100,000
Source: amfAR Opioid & Health Indicators Database
Source: National Electronic Disease Surveillance System (NEDSS)
Number of Reported Cases of HCV and HIV/AIDS in Northeast TN, 2007-2015
66.4% of Overdoses Attributable to Opioids 
in 2016

Law Enforcement Seizures of Fentanyl, 2015
Law Enforcement Seizures of Fentanyl, 2016
• Drug-overdose deaths
• Prescription opioid sales
• Per capita income
• White, non-Hispanic race/ethnicity
• Unemployment
• Buprenorphine prescribing potential by 
waiver
Source: amfAR Opioid & Health Indicators Database

What is Harm Reduction?
A set of policies, programs and practices aimed at reducing 
negative consequences associated with drug use or other 
risky behavior
Harm Reduction Strategies
• Information, education, communication
• Warning systems
• Motivational interviewing
• Medication assisted treatment
• Overdose reversal
• Needle and syringe programs
• Decriminalization
• Safe injection facilities
• Heroin prescribing



Key Harm Reduction Tenets
• Minimize harm vs ignore/condemn
• Functioning/wellbeing emphasis vs cessation
• Acknowledging continuum of behavior
• Non-judgmental
• Empowers users to be agents of harm reduction
• Recognizes the cumulative effect of social determinants
• Does not ignore potential harm/danger
Harm Reduction Goals
• Avoids exacerbating the harm caused by the misuse of drugs
• Treats drug users with dignity and as normal human beings
• Maximizes the intervention options
• Is based on the prioritizing of achievable goals
• Is neutral regarding legalization or decriminalization 
• Distinct from a war on drugs 
Syringe Service Programs (SSP)
Syringe Service Program
• Sterile needles and other injection equipment
• Safe disposal containers
• HIV/HCV testing
• Education
• Referral to substance abuse services
• Referral to medical, mental health, and social 
services
• Counseling, condoms, vaccination
• Overdose reversal training and equipment
Benefits
• Increase entry into substance abuse treatment by up to 5X
• Decrease or stop injecting drugs
• Reduces overdose deaths
• Reduce new HIV and HCV infections
• DO NOT increase drug use or crime
Benefits
• Access to population of drug users
– Research
– Policy development
– Provision of health services 
– Surveillance
• De-stigmatization
– Mental health improvement
– Re-integration into community
Stages of Change
• Exercise
• Health eating
• Smoking
• Drinking
• Going back to school
• Reading books
• Playing more with our kids
• Cleaning the house
• Flossing
• Paying bills
• Doing laundry
Current State of Affairs
Permitted
Legal
Illegal
Syringe Exchange Program Legality, 2017
Source: amfAR Opioid & Health Indicators Database
Syringe Exchange Programs, 2018 (N=318)
Source: amfAR Opioid & Health Indicators Database

Source: amfAR Opioid & Health Indicators Database
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